Dashboard
Manage Tickers

MDXGMIMEDX GROUP, INC.

Nasdaq mimedx.com


$ 6.84 $ 0.15 (2.24 %)    

Friday, 30-Aug-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 476.00 $ 5.61 (1.19 %)
DIA $ 416.44 $ 2.30 (0.56 %)
SPY $ 563.62 $ 5.33 (0.95 %)
TLT $ 96.60 $ -1.04 (-1.07 %)
GLD $ 231.30 $ -1.66 (-0.71 %)
$ 6.84
$ 6.84 x 700
-- x --
-- - --
$ 5.57 - $ 9.27
2,245,789
na
1B
$ 1.78
$ 6.70
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2024 06-30-2024 10-Q
2 04-30-2024 03-31-2024 10-Q
3 02-28-2024 12-31-2023 10-K
4 10-30-2023 09-30-2023 10-Q
5 08-01-2023 06-30-2023 10-Q
6 05-02-2023 03-31-2023 10-Q
7 02-28-2023 12-31-2022 10-K
8 11-02-2022 09-30-2022 10-Q
9 08-02-2022 06-30-2022 10-Q
10 05-03-2022 03-31-2022 10-Q
11 02-28-2022 12-31-2021 10-K
12 11-02-2021 09-30-2021 10-Q
13 08-03-2021 06-30-2021 10-Q
14 04-28-2021 03-31-2021 10-Q
15 03-08-2021 12-31-2020 10-K
16 11-04-2020 09-30-2020 10-Q
17 08-04-2020 06-30-2020 10-Q
18 07-06-2020 03-31-2019 10-Q
19 07-06-2020 06-30-2019 10-Q
20 07-06-2020 09-30-2019 10-Q
21 07-06-2020 12-31-2019 10-K
22 07-06-2020 03-31-2020 10-Q
23 03-17-2020 12-31-2018 10-K
24 10-31-2017 09-30-2017 10-Q
25 07-31-2017 06-30-2017 10-Q
26 05-01-2017 03-31-2017 10-Q
27 03-01-2017 12-31-2016 10-K
28 11-08-2016 09-30-2016 10-Q
29 08-02-2016 06-30-2016 10-Q
30 05-10-2016 03-31-2016 10-Q
31 02-29-2016 12-31-2015 10-K
32 11-06-2015 09-30-2015 10-Q
33 08-07-2015 06-30-2015 10-Q
34 05-01-2015 03-31-2015 10-Q
35 03-13-2015 12-31-2014 10-K
36 11-10-2014 09-30-2014 10-Q
37 08-11-2014 06-30-2014 10-Q
38 05-12-2014 03-31-2014 10-Q
39 03-04-2014 12-31-2013 10-K
40 11-08-2013 09-30-2013 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cantor-fitzgerald-reiterates-overweight-on-mimedx-group-maintains-11-price-target
Cantor Fitzgerald Reiterates Overweight on...
08/01/2024 17:03:01

Cantor Fitzgerald analyst Ross Osborn reiterates MiMedx Group (NASDAQ:MDXG) with a Overweight and maintains $11 price target.

craig-hallum-maintains-buy-on-mimedx-group-lowers-price-target-to-12
Craig-Hallum Maintains Buy on MiMedx Group...
08/01/2024 17:01:16

Craig-Hallum analyst Chase Knickerbocker maintains MiMedx Group (NASDAQ:MDXG) with a Buy and lowers the price target from $1...

mimedx-expects-2024-net-sales-growth-in-mid-to-high-single-digits-as-a-percentage-compared-to-2023
MIMEDX Expects 2024 Net Sales Growth In Mi...
07/31/2024 21:26:22

mimedx-group-announces-commercial-launch-of-heliogen-fibrillar-collagen-matrix-a-particulate-xenograft-product-for-complex-surgical-wounds-heliogen-contains-type-i-and-type-iii-collagen-and-mimics-native-structural-connective-tissue
MiMedx Group Announces Commercial Launch O...
07/31/2024 20:44:36

mimedx-group-q2-2024-adj-eps-008-inline-sales-87207m-miss-88919m-estimate
MiMedx Group Q2 2024 Adj. EPS $0.08, Inlin...
07/31/2024 20:11:55

MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.08 per share which met the analyst consensus estimate. The compan...

mimedx-publishes-first-study-in-top-journal-highlighting-regulatory-capabilities-of-dhacm-and-lhacm-allografts-on-fibrosis-expands-understanding-of-fibrotic-process
MiMedx Publishes First Study In Top Journa...
07/22/2024 12:12:56

analyst-bullish-on-mimedxs-rapid-growth-in-4b-woundcare-market-with-innovative-skin-substitutes
Analyst Bullish On MiMedx's Rapid Growth I...
07/02/2024 18:32:22

Cantor Fitzgerald has initiated coverage on MIMEDX, highlighting its strong market presence in wound care and surgical recovery...

cantor-fitzgerald-initiates-coverage-on-mimedx-group-with-overweight-rating-announces-price-target-of-11
Cantor Fitzgerald Initiates Coverage On Mi...
07/02/2024 10:46:37

Cantor Fitzgerald analyst Ross Osborn initiates coverage on MiMedx Group (NASDAQ:MDXG) with a Overweight rating and announce...

hc-wainwright--co-reiterates-buy-on-mimedx-group-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on MiMe...
05/01/2024 11:15:01

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MiMedx Group (NASDAQ:MDXG) with a Buy and maintains $11 pr...

mimedx-group-q1-2024-adj-eps-007-beats-004-estimate-sales-84709m-beat-79361m-estimate
MiMedx Group Q1 2024 Adj EPS $0.07 Beats $...
04/30/2024 20:43:06

MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.04 by...

the-fda-issued-determination-letter-for-mimedxs-request-for-designation-noting-axiofill-does-not-meet-regulatory-classification-requirements-of-a-human-cell-tissue-or-cellular-or-tissue-based-product
The FDA Issued Determination Letter For Mi...
03/27/2024 12:09:03

Core News & Articles
Tela Bio Announced Sale Of Distribution Ri...
03/20/2024 11:13:48

lake-street-initiates-coverage-on-mimedx-group-with-buy-rating-announces-price-target-of-12
Lake Street Initiates Coverage On MiMedx G...
03/07/2024 16:02:41

Lake Street analyst Brooks O'Neil initiates coverage on MiMedx Group (NASDAQ:MDXG) with a Buy rating and announces Price...

mizuho-maintains-buy-rating-for-mimedx-group-heres-what-you-need-to-know
Mizuho Maintains Buy Rating for MiMedx Gro...
03/01/2024 17:00:35

mizuho-maintains-buy-on-mimedx-group-raises-price-target-to-14
Mizuho Maintains Buy on MiMedx Group, Rais...
03/01/2024 14:48:30

Mizuho analyst Anthony Petrone maintains MiMedx Group (NASDAQ:MDXG) with a Buy and raises the price target from $13 to $14.

mimedx-group-sees-fy24-adj-ebitda-as-a-percent-of-net-sales-above-20
MiMedx Group Sees FY24 Adj. EBITDA As A Pe...
02/28/2024 21:37:29

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
02/28/2024 21:31:07

mimedx-group-q4-2023-adj-eps-004-misses-007-estimate-sales-8683m-beat-8505m-estimate
MiMedx Group Q4 2023 Adj EPS $0.04 Misses ...
02/28/2024 21:05:11

MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.07 ...

recap-mimedx-group-q4-earnings
Recap: MiMedx Group Q4 Earnings
02/28/2024 21:05:10

earnings-scheduled-for-february-28-2024
Earnings Scheduled For February 28, 2024
02/28/2024 11:24:02

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION